drugset / Trial / NCT02627027
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a randomized, open-label, single dose, 2-way crossover study to compare the pharmacokinetic characteristics of CKD-395 0.25/750 mg in healthy male volunteers.
Timeline
- Start
- 2015-08
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeglitazone | Small molecule | 0.25 mg | Oral |
| Subject | Lobeglitazone | Small molecule | 0.5 mg | Oral |
| Subject | Metformin | Small molecule | 750 mg | Oral |
| Subject | Metformin | Small molecule | 1500 mg | Oral |